Search for: "Accutane Litigation" Results 21 - 40 of 121
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Apr 2017, 3:47 am by Law Offices of Jeffrey S. Glassman
In these large multistate litigation matters, the judge is required to follow various choice of law provisions in state and federal statutes. [read post]
16 Sep 2016, 2:02 pm by Schachtman
Judge Johnson obviously had a good epidemiology teacher in Professor Stephen Goodman, who testified in the Accutane case. [read post]
7 Apr 2016, 11:34 am
Litig., No. 12-MD-2342, 2016 WL 1320799, at *11 (E.D. [read post]
31 Dec 2015, 5:12 am
  Thus some inordinately long-running litigation (more than seven years) finally came to an end. [read post]
9 Nov 2015, 7:09 am
 For instance, notwithstanding its eventual total victory, the maker of Accutane was forced to withdraw that drug from the market in 2009 due to the litigation cost of defending claims over purported side effects that either didn’t exist or were adequately warned about. [read post]
11 Sep 2015, 3:23 pm by Schachtman
Since expert testimony has become a mainstay of both civil and criminal litigation, this failure to communicate creates a conundrum in which jurists insist on testimony that experts are not capable of giving, and scientists attempt to conform their testimony to what the courts demand, often well beyond the limits of their expertise. [read post]
12 Jun 2015, 5:38 am
The summary judgment decision in In re Accutane Litigation, No. 271 (MCL), 2015 N.J. [read post]
5 Apr 2015, 7:50 pm by Schachtman
Pa. 2014) (excluding perinatal epidemiologist, Anick Bérard, for biased cherry picking of data points); In re Accutane, No. 271(MCL), 2015 WL 753674, 2015 BL 59277 (N.J.Super. [read post]
2 Apr 2015, 1:35 pm
This just in – after many years of litigation, the post April 10, 2002 warnings on Accutane were determined to be adequate as a matter of law by the New Jersey judge tasked with overseeing this mass tort. [read post]
28 Mar 2015, 9:24 am by Schachtman
Case Reports As so often is the case when there is no serious scientific evidence of harm in pharmaceutical cases, plaintiffs in the Accutane litigation relied heavily upon case and adverse event reports. [read post]
24 Mar 2015, 12:44 pm
  See In re Accutane Products Liability, 511 F. [read post]
9 Mar 2015, 7:48 am by Schachtman
In re Accutane Litig., No. 271(MCL), 2015 WL 753674 (N.J. [read post]
3 Mar 2015, 1:09 pm
 In In re Accutane Litigation, 2015 WL 753674 (N. [read post]
4 Aug 2014, 12:48 pm
Congratulations to Covington and Burling, which we think has now won reversal of every adverse Accutane verdict in the New Jersey mass tort litigation, and a tip of the cyberhat to Mike Imbroscio, for sending Gaghan to us. [read post]
22 Jul 2014, 6:57 am
That’s the lesson of the recent California trial court decision in In re Accutane Drug Cases, Coord. [read post]
21 Feb 2014, 8:53 am
”  In re Fosamax Products Liability Litigation, 2013 WL 174416, at *1 (S.D.N.Y. [read post]
12 Jul 2013, 4:30 am by Steve McConnell
 Every once in a while we have the opportunity to blog about drug and device developments north of the border, involving matters also being litigated in the USA. [read post]
25 Apr 2013, 5:00 am by Bexis
E-350 Van Products Liability Litigation (No. [read post]